Similar articles

• Foscarnet therapy of ganciclovir-resistant cytomegalovirus in marrow transplantation.

  Drobyski WR, Knox KK, Carrigan DR, Ash RC. Drobyski WR, et al. Transplantation. 1991 Jul;52(1):155-7. Transplantation. 1991. PMID: 1650043 No abstract available.
• Extrapulmonary cytomegalovirus disease in transplant patients.

  Petersen EA. Petersen EA. Transplant Proc. 1991 Apr;23(2 Suppl 1):13-6. Transplant Proc. 1991. PMID: 1647557 Review. No abstract available.
• Ganciclovir and standard high-dose immunoglobulins for the treatment of cytomegalovirus interstitial pneumonia in a bone marrow recipient.

  Iori AP, Gentile G, Petasecca Donati P, Arcese W, Martino P, Mandelli F. Iori AP, et al. Haematologica. 1990 Jul-Aug;75(4):394-6. Haematologica. 1990. PMID: 2177441
• Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir.

  Verdonck LF, de Gast GC, Dekker AW, de Weger RA, Schuurman HJ, Rozenberg-Arska M. Verdonck LF, et al. Bone Marrow Transplant. 1989 Mar;4(2):187-9. Bone Marrow Transplant. 1989. PMID: 2539877
• [Cytomegalovirus infections in transplant patients].

  Charpentier B. Charpentier B. Presse Med. 1991 Jun 22;20(24):1107-8. Presse Med. 1991. PMID: 1649473 Review. French. No abstract available.